Video


  • PEIP 2025: Heavyweight Battle: Semaglutide vs Tirzepatide (and other weight loss meds)

1. Discuss and compare evidence for new drugs for weight loss. 2. Review current evidence of harm, including post marketing data. 3. Review present costs of medications available for weight loss….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here


CFPCLearn Logo

Watching the Video can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



December 1, 2025

This content is certified for MainPro+ Credits, log in to access

🔒 Complete Activity

Speaker(s):

  • Adrienne Lindblad BSP ACPR Pharm

Please refer to the video for conflict of interests